Author Question: In which section of the SOAPIER format should the patient's response to a specific treatment ... (Read 45 times)

arivle123

  • Hero Member
  • *****
  • Posts: 569
In which section of the SOAPIER format should the patient's response to a specific treatment modality be recorded?
 
  a. Assessment
  b. Implementation
  c. Observation
  d. Evaluation

Question 2

All of the following are anatomic alterations of the lungs that may be found with the chronic stage of interstitial lung disease (ILD) EXCEPT:
 
  a. honeycombing.
  b. edema.
  c. interstitial thickening.
  d. granulomas.



bblaney

  • Sr. Member
  • ****
  • Posts: 323
Answer to Question 1

D
Measurable data regarding the effectiveness of a therapy plan and the patient's response to the treatment would be recorded under Eevaluation.

Answer to Question 2

B
Honeycombing, interstitial thickening, and granulomas are associated with the chronic stages of interstitial lung disease.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

According to the American College of Allergy, Asthma & Immunology, more than 50 million Americans have some kind of food allergy. Food allergies affect between 4 and 6% of children, and 4% of adults, according to the CDC. The most common food allergies include shellfish, peanuts, walnuts, fish, eggs, milk, and soy.

Did you know?

The use of salicylates dates back 2,500 years to Hippocrates's recommendation of willow bark (from which a salicylate is derived) as an aid to the pains of childbirth. However, overdosage of salicylates can harm body fluids, electrolytes, the CNS, the GI tract, the ears, the lungs, the blood, the liver, and the kidneys and cause coma or death.

Did you know?

Today, nearly 8 out of 10 pregnant women living with HIV (about 1.1 million), receive antiretrovirals.

Did you know?

Approximately one in three babies in the United States is now delivered by cesarean section. The number of cesarean sections in the United States has risen 46% since 1996.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library